Market cap
$50.4m
End-of-day close multiplied by current shares on issue.
Result releasedAnnolyse analysis published
FY24 NPAT of $4.6m sits against an insurance-boosted FY23 base, inventory days extended to 133, and cash fell $7.7m to $31.6m.
Revenue context before the current result.
EBITDA margin across covered periods.
Operating cash flow across covered periods.
Operating working-capital absorption or release by reporting period.
Market context
A close-dated read on what the market price implies next to the latest verified filing inputs. Unavailable metrics stay visible when the absence is useful context.
The latest close and share count context for the market price.
Market cap
$50.4m
End-of-day close multiplied by current shares on issue.
How the market price compares with recent earnings and cash-flow inputs.
P/E
Not available
Not meaningful when recent earnings are negative.
EPS
-0.09
Recent filing-derived earnings per share.
PEG
Not available
Not available for this company right now.
EV/EBITDA
Not available
Not available for this company right now.
P/FCF
Not available
Not meaningful when free cash flow is negative or unavailable.
P/B
0.77x
Market value compared with latest reported equity.
Yield and fund-style valuation where the company shape supports it.
Dividend yield
0.0%
Trailing dividends compared with the latest close.
Total return
Not available
Available once dividend and adjustment data are verified.
Key metrics
FY24 vs FY23
Revenue
$80.3m
Caveat: metric quality flags apply; use this value with basis context.
Net profit after tax
$4.6m
Caveat: metric quality flags apply; use this value with basis context.
Net cash inflow from operating activities
−$27.3m
Caveat: metric quality flags apply; use this value with basis context.
Operating profit
$4.4m
Caveat: metric quality flags apply; use this value with basis context.
Profit before tax
$4.9m
Caveat: metric quality flags apply; use this value with basis context.
Cash and cash equivalents
$31.6m
-19.5% ↓ vs $39.3m
Total assets
$94.9m
Caveat: metric quality flags apply; use this value with basis context.
Analysis ofBRW FY24Result releasedAnnolyse analysis published
What changed
After capex of $4.0m, free cash flow before lease payments was approximately -$31.3m.
Headline profit fell to $4.6m NPAT and $4.4m operating profit, against $11.0m and $11.8m respectively. The like-for-like read is constrained by a basis discontinuity: FY23 NPAT included $35.5m of insurance proceeds related to Cyclone Gabrielle (cumulative proceeds to date $62.0m). Revenue printed at $80.3m versus $89.7m. Cash on hand declined $7.7m to $31.6m, while equity rose to $54.4m.
What matters
Expectations
The company has signalled a return to dividends by FY26, which implicitly requires sustained profitability and a more normal cash-conversion profile than FY24 delivered. The supplied interim context shows HY24 NPAT of -$1.7m, implying a roughly $6.3m second-half NPAT and $41.3m of second-half revenue. That shape supports management's narrative that supply restoration was beginning to translate into trading recovery, but it is a single half-year data point rather than an established trend.
This briefing has no forward-work or order-book context to test that recovery against, so the trajectory beyond FY24 depends on sell-through of the elevated inventory and on demand in a soft retail and construction backdrop.
Quality of result
Reported NPAT of $4.6m converted to operating cash outflow of -$27.3m, with the FCF-to-NPAT ratio at -674.8%. Even allowing for the inventory build, this is a result where the income statement and the cash statement are pointing in different directions, which matters because the income line is the more flattering of the two.
The effective tax rate rose to 6.1% from 2.3%, still well below a statutory rate, so NPAT is modestly tax-flattered relative to the $4.9m PBT. The $4.4m operating profit is the cleanest read of underlying trading and is sharply below FY23's $11.8m even before adjusting for insurance distortion. Capex doubled to $4.0m, indicating reinvestment that should be tracked against the dividend-by-FY26 commitment. Equity grew $3.9m to $54.4m, broadly consistent with retained earnings, so the balance sheet is absorbing the cash drain rather than the recovery being funded by new capital.
Unresolved
This briefing cannot assess segment-level revenue or margin performance for carpet versus wool, gross margin trends, or the order book underpinning the implied second-half recovery, because none of those are disclosed in the supplied material.
Chat
Ask follow-up questions about Bremworth's FY24 result.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Open to load analytical metrics.
Open to load key metrics.
BRWFY24AuditedFinancialStatements
FY24 / financial reportBRWFY24ResultsMarketRelease
FY24 / results releaseNZXFY24ResultsTemplate
FY24 / results announcementBRWFY23ResultsMarketRelease
FY23 / results releaseBRWFY23UnauditedFinancialStatements
FY23 / financial reportNZXFY23ResultsTemplate
FY23 / results announcement1H24ChairAndCEOCommentary
HY24 / results release1H24FinancialResultsAnnouncement
HY24 / results announcement1H24HalfYearReport
HY24 / financial reportAGM Presentation
HY24 / commentaryRelated insights
Cross-company views selected from the metrics in this briefing.
Earnings quality and statutory distortions
PBT and NPAT growth diverged by 1.6pp, with a distortion flag in the result.
Working-capital pressure
Inventory days were 133 days, +46 days versus the prior comparable period.
ROE and capital efficiency
ROE was 8.5%, -13.3pp versus the prior comparable period.
Revenue growth context
Revenue growth was -10.5% for this reporting period.
Get the next Bremworth briefing and related NZX reporting-season updates by email.